Search Results 1461-1470 of 18416 for Immunode
- Participants with known human immunodeficiency virus (HIV)-infection must be receiving anti-retroviral therapy and have an undetectable viral load test on ...
... immunodeficiency virus (HIV)*), which in the investigator's opinion makes it undesirable for the patient to participate in the study or which would ...
* Active hepatitis B or C infection and/or known human immunodeficiency virus (HIV) carrier. * Poorly controlled gastrointestinal disorders. Note: Other ...
Known history of positive test for human immunodeficiency virus (HIV) or known acquired immunodeficiency syndrome (testing at Screening is not required). If ...
Immunodeficiency disorder or; Weakened immune system—This vaccine may not work as well in children with these conditions. Previous serious reaction to a ...
[MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.
Immunocompromised patients and patients known to be human immunodeficiency virus (HIV) positive and currently receiving antiretroviral therapy; Note ...
The participant has an active fungal, bacterial, and/or known viral infection including human immunodeficiency virus (HIV) or viral (A, B, or C) hepatitis ...
About this study. The purpose of this research is to identify an association between bacterial species and strains and active hidradenitis suppurativa (HS) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.